Data / Form D filings / VERAX BIOMEDICAL INC
VERAX BIOMEDICAL INC: Form D filings
VERAX BIOMEDICAL INC, a biotechnology company in Marlborough, MA, filed 11 Form D notices with the SEC between 2009 and 2019. The latest, on September 19, 2019, reports $2.5 million sold of a $10.5 million offering to 5 investors.
Find out what VERAX BIOMEDICAL INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- c/o Verax Biomedical Incorporated, 148 BARTLETT STREET, Marlborough, MA, 01752
- Phone
- (508) 755-7029
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1161304
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 19, 2019 | New notice | $10,538,912 | $2,538,912 | $8,000,000 | 5 | Sep 5, 2019 | sec.gov |
| Nov 13, 2017 | New notice | $24,090,000 | $11,439,595 | $12,650,405 | 4 | Oct 26, 2017 | sec.gov |
| Jun 27, 2016 | Amendment | $24,548,586 | $12,614,469 | $11,934,117 | 64 | Feb 18, 2016 | sec.gov |
| Mar 2, 2016 | New notice | $12,554,365 | $12,554,365 | $0 | 56 | Feb 18, 2016 | sec.gov |
| Jan 21, 2015 | New notice | $4,000,000 | $4,000,000 | $0 | 61 | Jan 7, 2015 | sec.gov |
| Oct 15, 2013 | Amendment | $11,781,992 | $8,499,302 | $3,282,690 | 83 | Jul 22, 2013 | sec.gov |
| Jul 31, 2013 | New notice | $11,781,992 | $6,831,992 | $4,950,000 | 31 | Jul 22, 2013 | sec.gov |
| Oct 25, 2012 | Amendment | $5,000,000 | $3,298,121 | $1,701,879 | 86 | Jul 31, 2012 | sec.gov |
| Aug 14, 2012 | New notice | $5,000,000 | $2,788,313 | $2,211,687 | 11 | Jul 31, 2012 | sec.gov |
| Mar 22, 2011 | New notice | $1,287,036 | $1,287,036 | $0 | 26 | Mar 9, 2011 | sec.gov |
| Apr 15, 2009 | New notice | $10,000,000 | $2,079,142 | $7,920,858 | 12 | Apr 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Lousararian | Executive Officer, Director | |
| Paul Ragusa | Executive Officer | |
| Joe Sanders | Director | |
| Robert Flanagan | Director | |
| Marc Goldberg | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Sep 16, 2019 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VERAX BIOMEDICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.